The glioma ampli®ed sequence 41 (GAS41) was previously isolated by microdissection mediated cDNA capture from the glioblastoma multiforme cell line TX3868 and shown to be frequently ampli®ed in human gliomas. We determined the complete cDNA sequence of the GAS41 gene, demonstrated that the GAS41 protein is evolutionarily conserved, speci®cally at the Nterminus, and identi®ed the yeast transcription factor tf2f domain within the GAS41 sequence. A human multiple-tissue Northern blot revealed ubiquitous expression of GAS41 with the highest expression in human brain. After generating polyclonal antibodies we found GAS41 protein expression in the nucleus of the TX3868 cell line by Western blot analysis and immuno¯uores-cence microscopy. The nuclear localization was con®rmed for several human tumors including gliomas of dierent grades of malignancy. In neuroblastoma however, GAS41 was found in the nucleoli but not in the nucleoplasm. Yeast two-hybrid screening of the TX3868 cell line identi®ed the nuclear mitotic apparatus protein (NuMA), the KIAA1009 protein, and prefoldin subunit 1 (PFDN1) as potential interacting partners of GAS41. We generated a polyclonal antibody against the KIAA1009 protein and we demonstrated that the KIAA1009 protein is a nuclear protein, which appears to be co-localized with the GAS41 protein and NuMA.
Introduction
Glioma is a collective name for tumors of glial cells including astrocytes. Gliomas of astrocytic origin are the most common primary brain tumors and account for 40% of the central nervous system tumors (Sehgal, 1998; Kleihues et al., 1995) . The Glioma Ampli®ed Sequence 41 (GAS41), originally isolated from the glioblastoma multiforme (GBM) cell line TX3868 by microdissection mediated cDNA capture (Fischer et al., 1996) , was found to be frequently ampli®ed in human gliomas (Fischer et al., 1997) . The TX3868 cell line contains a homogeneously staining region (hsr) with ampli®ed sequences on chromosome 12q13 ± 15. Abnormalities like hsr and/or double minutes are frequently found in human tumors and thought to be a manifestation of the intrinsic genomic instability of cancer cells. In addition, it is presumed that overexpression of ampli®ed genes confers a selective advantage on such cell clones (Livingstone et al., 1992; Fischer et al., 1996) . Therefore, over-expressed proteins could potentially play an important role in tumorigenesis (Suzuki and Iwaki, 2000; Murakami et al., 2000) . GAS41 shows an increased copy number in pilocytic astrocytomas, an entity of gliomas that usually occurs in the pediatric population and corresponds to WHO grade I and in gliomas of the adult which represent a separate tumor entity (Fischer et al., 1997) .
To learn more about the possible function of GAS41 and its over-expression in the GBM cell line TX3868, the deduced structure of the GAS41 protein was compared to other proteins. GAS41 has a potential C-terminal a-acidic activation domain common to eukaryotic transcription factors (Mitchell and Tjian, 1989; Remacle et al., 1997) but no potential DNA binding domain. We reported previously that GAS41 is homologous to the yeast transcription factor AF-9 and to the human transcription factors AF-9 and ENL (Fischer et al., 1997) . Because of these similarities, the potential C-terminal a-acidic activation domain and the lack of a potential DNA-binding domain, we suggested that GAS41 could be an incomplete transcription factor.
In this study, we report the complete nucleotide sequence of the human GAS41 gene, and compare the encoded GAS41 protein sequence to proteins from diverse species using the BLAST-P, BLAST-X and BLAST-N algorithms. We were able to identify a conserved tf2f domain in GAS41 that is also present in other transcription factors of yeast and humans. The GAS41 gene is expressed in various human tissues as demonstrated by Northern blot analysis and immunohistochemical staining. Using polyclonal antibodies speci®c for the GAS41 C-terminus, we localized GAS41 protein expression in the nucleus by Western blot analysis, immuno¯uorescence microscopy and immunohistochemical staining. To further investigate the function of the GAS41 gene, we used the yeast two-hybrid system to identify potential binding partners of the GAS41 protein by screening the TX3868 GBM cell line.
Results
The nucleotide and corresponding amino acid sequence of human GAS41 is shown in Figure 1 . The cDNA sequence of 1444 basepairs (bp) revealed a single open reading frame with two ATG codons located 12 bases Figure 1 The nucleotide and corresponding amino acid sequence of human`glioma ampli®ed sequence' (GAS41). The sequence data is available in the NCBI database under the accession number U61384. The corresponding amino acids are placed under the coding nucleotides. The 3' polyadenylation signal, AATAAA, is underlined. The peptide sequence used for generating polyclonal antibodies are shaded: K 36 KREEDGHTHQWT 48 for the N-terminal antibody GAS41-N and K 212 NEIRKLEEDDQAKDI 227 for the C-terminal antibody GAS41-C. The positions of the used primers are marked as GAS41 for and GAS41rev apart at positions 222 and 234. A 481 bp 3' untranslated region¯anks the coding sequence with a polyadenylation sequence (AATAAA) located at position 1362. The human GAS41 gene sequence that contains seven exons potentially encodes a protein with 227 amino acids and a calculated molecular mass of 26.5 kDa. Using the BLAST-P, BLAST-X, and BLAST-N algorithms, we examined the conservation of the human GAS41. As demonstrated in Figure 2 , the GAS41 protein is highly conserved among species, especially at the N-terminus (position R15-L120). For some species no complete protein sequence was available in the databases. In these cases, we used the EST (expressed sequence tag) database to identify nucleotide sequences similar to the GAS41 nucleotide sequence.
Using ClustalW program we demonstrated high similarities and identities between the human GAS41 protein and proteins of other species as summarized in Table 1 . High identities and similarities are found for vertebrates such as Rattus norvegicus (AI031024 and AI012982), Mus musculus (AA529582 and AA086873), Sus scrofa (AW314206), Bos taurus (AV597623), Gallus gallus (AJ396415), and Xenopus laevis (AW767025) ranging from 85.2% for Bos taurus to 100% for Sus scrofa. Using the BLAST-P algorithm, we furthermore identi®ed proteins similar to the human GAS41 protein in Drosophila melanogaster (AAF52462), Caenorhabditis elegans (CAB1234), Saccharomyces cerevisiae (P53930) and Schizosaccharomyces pombe (Q10319). However, their protein sequences have lower identities and similarities compared to the vertebrate species. The protein encoded by the CG92907 gene of Drosophila melanogaster (AAF52462) has a similarity of 62% and an identity of 52% to the complete human GAS41 and is predicted to be a 195 amino acid transcription factor (FlyBase, 1999; Adams et al., 2000) . The most similar protein from Caenorhabditis elegans (CAB01234) is 211
Figure 2 Alignment of the GAS41 protein (U61384) with homologous database sequences demonstrates conservation of GAS41 in 11 dierent species. Identical amino acids (aa) are inverted, similar aa are shaded. Gaps inserted by the sequence alignment software (ClustalW) are indicated by horizontal strokes (7). The used open reading frame (ORF's) and expressed sequences taqs (EST's) are all traceable in the database. For Rattus norvegicus (AI031024 and AI012982), Mus musculus (AA529582 and AA 086873), Sus scrofa (AW314206), Bos taurus (AV314206), Gallus gallus (AJ396415), and Xenopus laevis (AW767025) only partial sequences are in the database. Missing sequence parts are indicated by horizontal strokes (7). The complete ORF's for Drosophila melanogaster (AAF5242), Caenorhabditis elegans (CAB01234), Saccharomyces cerevisiae (P53930), and Schizosaccharomyces pombe (Q10319) are known amino acids in length with similarity to the AF-9 protein, a transcription factor as well (Figure 2 ). The most homologous Saccharomyces cerevisiae protein (P53930) to human GAS41 is 226 amino acids in length with a calculated molecular mass of 26.0 kDa and like the Schizosaccharomyces pombe protein (Q10319) shares similarities with the human transcription factors AF-9 and ENL and the small subunit of the yeast transcription initiation factor TFIIF.
To identify the presence of conserved domains within the GAS41 protein sequence, we utilized the NCBI conserved domain database which de®nes conserved domains based upon recurring sequence patterns or motifs (Altschul et al., 1997) . We identi®ed the tf2f domain conserved for the human GAS41 protein sequence with an expected value of 26e 726 as shown in Figure 3 . A tf2f domain is also present in the human transcription factor ENL, and the yeast ACN1 protein, which is identical to the transcription initiation factor TFIIF small subunit.
We performed a human multiple-tissue Northern blot analysis using RNA isolated from human heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas as shown in Figure 4 . Using a 220 bp fragment from the GAS41 gene as probe, a *1.4 kb transcript was detected in all of the eight tissues tested. It appears that the GAS41 protein is expressed in many human tissues. After normalization with a GAPDH probe GAS41 appeared to show elevated expression in brain.
We generated polyclonal antibodies speci®c for GAS41, and chose amino acids 36 ± 48 with the peptide sequence, KKREEDGHTHQWT, to generate the polyclonal antibody GAS41-N against the aminoterminus (Figure 1) . A second peptide sequence, KNEIRKLEEDDQAKDI, corresponding to the amino acids 212 ± 227 was used to generate the GAS41-C polyclonal antibody against the carboxy-terminus (Figure 1 ). After peptide synthesis, rabbits were immunized, and blood was obtained for preparation of antibody-containing serum. Before and after puri®cation of the sera on peptide binding columns, both polyclonal antibodies, GAS41-N and GAS41-C, were tested for their speci®city. To this end, a GAS41 sequence was cloned into the pGEX4T1 vector and recombinantly expressed as a GST-GAS41 fusion protein detectable with both antibodies (data not shown).
To further test the speci®city of the GAS41-C antibody for GAS41 protein, we performed a Western blot analysis using the protein lysate prepared from the GBM cell line TX3868 ( Figure 5A ). The GAS41-C antibody reacts speci®cally with a protein of 26.5 kDa, which is the expected size of the GAS41 protein. When the peptide used to generate the GAS41-C antibody is incubated with the puri®ed GAS41-C serum, it eectively blocks the binding to GAS41 demonstrating the speci®city of the puri®ed GAS41-C polyclonal antibody. To con®rm that the 26.5 kDa signal is not generated by a non-speci®c interaction with the secondary antibody, we incubated the Western blot with the anti-rabbit secondary antibody only. No signal was revealed with the anti-rabbit secondary antibody. To initially examine the subcellular distribution of the GAS41 protein, Western blot analysis was performed on both nuclear and cytoplasmic fractions of the TX3868 GBM cell line using the GAS41-C polyclonal antibody. As shown in Figure 5B , GAS41 is located predominantly in the nucleus as only the 26.5 kDa protein is clearly revealed in the nuclear fraction and in the total protein lysate. To verify the separation of nuclear and cytoplasmic fractions, the fractions were incubated with an antibody against the human Ki67 protein that is located in the nucleus only (data not shown).
Using the GAS41-C antibody for immunohistochemical staining and in immuno¯uorescence microscopy experiments, we determined the GAS41 protein expression pattern in the nucleus of various tissue sections and cell types. As shown in Figure 6B , GAS41 protein is expressed in the nucleus of dierent normal tissues like human heart, placenta and brain, as well as in normal rat brain. Furthermore it is expressed in the nucleus of dierent neoplastic tissues like human malignant gliomas, medulloblastomas, and in rat C6 gliomas. The ®ndings of GAS41 expression in normal tissues con®rm our Northern blot experiments. In rats with stereotactically implanted C6 gliomas GAS41-immunoreactivity of normal brain tissue and tumor tissue can be compared within the same tissue section. The expression of GAS41 in the tumor is higher than in the directly adjacent pre-existing normal brain tissue. All tested gliomas contained at least some GAS41-immunopositive cells, whereas the intensity of staining was independent of the grade of malignancy (data not shown).
To examine the subcellular distribution of GAS41 on a more sensitive level we employed immunocytochemical staining. As shown in Table 2 the following cell cultures and cell lines respectively express the GAS41 protein in the nucleoplasm but not in the nucleoli: A cell culture derived from an astrocytoma grade I (T5498), six cell cultures derived from astrocytomas grade II (T4747, T4761, T4772, T4951, T5184 and T5473), the cell line TX3868, the GBM cell culture T5135, a meningioma cell culture, the prostate carcinoma cell line PC 3, the breast carcinoma cell line MCF-7, the HeLa cells, the cell culture of primary astrocytes NHA, and the cell culture of ®broblasts KH5436. All these cells show the same localization of the GAS41 protein exemplarily documented for T4761 and TX3868 ( Figure 6A , e ± h). In contrast cells of the neuroblastoma cell lines SK-N-SH, Neuro 2a, and NS20Y express GAS41 speci®cally in the nucleoli and not in the nucleoplasm as con®rmed by the double staining with the Nucleolin-speci®c antibody (data not shown). This subcellular distribution of the GAS41 protein in neuroblastoma is exemplarily documented for SK-N-SH and Neuro 2a ( Figure 6A , a ± d).
Because GAS41 contains a C-terminal acidic activating domain frequently found in eukaryotic transcription factors (Mitchell and Tjian, 1989; Remacle et al., 1997) and lacks a typical DNA-binding domain for transcriptional activation, we ®rst determined its potential capability of transactivating yeast transcription using the yeast-two hybrid system. As shown in Figure 7A , the hybrid protein of GAS41 and the DNA binding domain of the arti®cial yeast system expressed from the pBD/GAS41 construct (GAS41 DNA from position 300 ± 929 cloned into the pBD-Cam vector) does not activate transcription of the LacZ gene. Because the GAS41 activating domain together with the DNA-binding domain of the yeast two-hybrid system does not activate the LacZ repressor gene, the system could be used to search for protein interacting partners of the GAS41 protein.
We cloned cDNA from the GBM cell line TX3868 into the pAD vector of the yeast two-hybrid system to identify interacting partners of GAS41. The resulting construct was called pAD/TX3868 and was cotransformed with the pBD/GAS41 construct into the YRG-2 yeast strain. The resulting fusion protein GAL4-BD/GAS41 was used as`bait' to screen the human GBM cell line TX3868. Screening 300 000 yeast clones, we observed b-galactosidase expression in 13 Figure 5 (A) Speci®city of the GAS41-C polyclonal antibody for GAS41 expressed in the glioblastoma multiform cell line TX3868 by Western blot analysis. Lanes 1 ± 3 contain protein lysates of TX3868. Lane 1 was incubated ®rst with the GAS41-C polyclonal antibody and subsequently with a secondary anti-rabbit antibody, revealing the GAS41 protein with the expected size of 26.5 kDa. Lane 2 was incubated with the GAS41-C peptide and the GAS41-C polyclonal antibody ®rst and subsequently with the secondary anti-rabbit antibody. Lane 3 was incubated with only the secondary anti-rabbit antibody (B) Localization of the GAS41 protein by Western blot analysis of nuclear and cytoplasmic fractions of the TX3868 cells using the GAS41-C polyclonal antibody. Lane 1 contains total protein lysate, Lane 2 the cytoplasmic fraction, and Lane 3 the nuclear fraction of the TX3868 cells. (C) Speci®city of the KIAA1009 polyclonal antibody for KIAA1009 expressed in the glioblastoma multiform cell line TX3868 by Western blot analysis. Lanes 1 and 2 contain protein lysates of TX3868. Lane 1 was incubated ®rst with the KIAA1009 polyclonal antibody and subsequently with a secondary anti-rabbit antibody, revealing the KIAA1009 protein with the expected size of 153 kDa. Lane 2 was incubated with the KIAA1009 peptide and the KIAA1009 polyclonal antibody ®rst and subsequently with the secondary anti-rabbit antibody (D) Localization of the KIAA1009 protein by Western blot analysis of nuclear and cytoplasmic fractions of the TX3868 cells using the KIAA1009 polyclonal antibody. Lane 1 contains total protein lysate, Lane 2 the nuclear fraction, and Lane 3 the cytoplasmic fraction of the TX3868 cells clones. We isolated the DNAs from these clones, sequenced the DNA, and re-transformed each DNA with the pBD/GAS41 construct into the yeast strain YRG-2 to verify the LacZ and HIS3 interactions for Figure 8A ) (Richard et al., 1997) . Double staining with a monoclonal antibody speci®c for NuMA (Transduction Laboratories) and GAS41-C antibody indicates the same subcellular localization of the GAS41 protein and NuMA ( Figure 6A, i ± k) .
The PFDN1 clone is composed of 1322 bp with the ORF between position 48 bp and 414 bp ( Figure 8C ). The portion of the PFDN1 protein that interacts with GAS41 is encoded by the sequence between positions 333 bp and 414 bp. PFDN1 is a subunit of prefoldin, that plays an essential role in the folding of native proteins like actin and/or tubulin, functioning as a chaperone (Vainberg et al., 1998; Hansen et al., 1999) .
The sequence of the KIAA1009 clone that was originally isolated in the Kazusa cDNA project (Nagase et al., 1999) is 5103 bp long with an ORF from position 251 bp to position 4234 bp ( Figure 8B ). The portion of the KIAA1009 protein that interacts with GAS41 is encoded by the sequence from position 690 bp to 2510 bp. To generate a polyclonal antibody we chose amino acids 252 ± 265 with the peptide sequence CENEENSKNISTMES, corresponding to the KIAA1009 protein sequence with the accession number XM 004364. To test the antibody for its speci®city a KIAA1009 sequence from position 694 ± 2468 bp (XM 004364) was cloned into the pQE-30 vector and recombinantly expressed. The correspond- Using the protein lysate prepared from the GBM cell line TX3868, the KIAA1009 antibody reacts with a 153 kDa protein in the Western blot analysis ( Figure  5C ). This size corresponds to the expected size of the KIAA1009 protein. The binding to the KIAA1009 protein is eectively blocked using the peptide which was used to generate the KIAA1009 antibody ( Figure  5C ).
To examine the subcellular distribution of the KIAA1009 protein we employed Western blot analysis and immuno¯uorescence microscopy. Using both nuclear and cytoplasmic fractions of the TX3868 GBM cell line, Western blot analysis shows KIAA1009 protein in the nucleus, but not in the cytoplasmic fraction ( Figure 5D ). These results are consistent with the immuno¯uorescence microscopy experiments (Figure 6A, n) . In addition, double staining indicates the same subcellular distribution of the GAS41 protein and the KIAA1009 protein ( Figure 6A , l ± n).
Discussion
Gene ampli®cation in eukaryotes plays an important role in drug resistance, tumorigenesis, and evolution (Albrecht et al., 2000) . Speci®cally in human gliomas, gene ampli®cation is proposed to be a decisive event that contributes to tumorigenesis (Heiskanen et al., 2000) . The ampli®cation of the GAS41 gene in grade II diuse gliomas provided the ®rst evidence of an ampli®cation present in low-grade human gliomas, suggesting that this gene is involved in the early process of tumorigenesis (Fischer et al., 1997) .
The function of the GAS41 protein is suggested, in part, by the primary amino acid sequence and by comparisons with other proteins in the databases. An enrichment of acidic amino acids (27%) within a stretch of 60 amino acids in the C-terminus suggests that GAS41 may be a transcription factor as this kind of negatively charged acidic a-helical structure is typical for activation domains in eukaryotic transcription factors (Mitchell and Tjian, 1989; Remacle et al., 1997) . Previously, GAS41 was shown to have a high similarity to the yeast AF-9 protein and to the human AF-9 and ENL proteins, which are involved in translocation events and are suggested to belong to a new class of transcription factors (Nakamura et al., 1993) . Human GAS41 appears to be an incomplete transcription factor because it lacks a DNA binding domain.
In this report, we demonstrated that the GAS41 protein is not only highly conserved within the species of mammals. Generally, the highest conservation was found in vertebrates and a lower identity/ similarity in non-vertebrates like Drosophila melanogaster (AAF52462), Caenorhabditis elegans (CAB01234), Saccharomyces cerevisiae (P53930) and Schizosaccharomyces pombe (Q10319). The proteins of these four species are partially characterized as probable transcription factors in the NCBI database and show similarities to the AF-9 transcription factor as well.
GAS41 contains a tf2f domain that is present in the yeast transcription factor TFIIF and in other transcription factors such as the human transcription factor ENL and in the yeast ACN1 protein. The tf2f domain is described as a conserved domain in the transcription factor TFIIF of ®ssion yeast Schizosaccharomyces pombe and is predicted to be a chromatin modifying protein. The yeast ACN1 protein, which contains the tf2f domain as well, is also identical to the transcription initiation factor TFIIF small subunit and is an integral member of two basal transcription factor complexes, TFIID and TFIIF. ACN1 is an interacting component of the SWI/SNF chromatin remodeling complex (Cairns et al., 1996) . It interacts with the SWI/ SNF complex by binding to the SNF5 protein. The Snr1 protein of Drosophila is similar to the SNF5 protein and has been shown to be associated in large complexes equivalent to the yeast SWI/SNF (Wang et al., 1996) . The human protein INI1 is similar to SNF5 and may be part of an equivalent human complex. These database comparisons also demonstrate that GAS41 is highly conserved among eukaryotes and is likely to function as a transcription activation domain.
Several lines of evidence indicate that GAS41 is a transcription factor including the negatively charged acidic a-helical activation domain, high similarities to other transcription factors and its expression in the nucleus. Since GAS41 is missing a DNA binding domain, we used the yeast two-hybrid system to test the ability of GAS41 to transactivate yeast transcription on its own and then to identify protein interacting partners of GAS41. GAS41 was not able to transactivate yeast transcription on its own probably because this process requires that several components including DNA-binding proteins, transactivation proteins, coactivators and accessory proteins must be present (Martin, 1991; NaÈ aÈ r et al., 1999) .
It is important to notice that there are described dierences in transactivation between organisms like human and yeast (Carlson and Laurent, 1994) . For example, the yeast transcription factor GCN4 containing an acidic activation domain needs the co-activators ADA2, ADA3 and CGN5 (Barlev et al., 1995) . In mammalian cells many DNA binding domains need the coactivator p300/CBP to initiate transcription (Jahnknecht and Hunter, 1996) . Using the yeast-two hybrid system, we did identify three potential binding partners for GAS41: NuMA (nuclear mitotic apparatus protein), KIAA1009 protein and PFDN1 (subunit 1 of prefoldin).
KIAA1009 was originally identi®ed in the course of sequencing cDNA clones from size-fractionated human brain cDNA libraries (Nagase et al., 1999) . The KIAA1009 clone is expressed in heart, brain, lung, liver, skeletal muscle, kidney, pancreas, spleen, testis, ovary and diverse brain regions with the lowest expression in the spleen, and the highest expression in the ovary (Nagase et al., 1999) . We found expression of the KIAA1009 clone in leukocytes and in the glioblastoma cell line TX3868 (data not shown). The only indication of function for the KIAA1009 clone is its possible interaction with GAS41. We generated a polyclonal antibody speci®c for the KIAA1009 protein and demonstrated that KIAA1009 is located in the nucleus only. Immuno¯uorescence microscopy indicates co-localization of the GAS41 protein, the KIAA1009 protein and NuMA. These results are consistent with the idea of the interaction of these three proteins.
NuMA is a component of the putative mitotic spindle matrix in vertebrates (Dionne et al., 1999) and shows a striking change in location during the cell cycle, moving from the nuclear matrix in interphase to the spindle poles in mitotic cells (Lyderson and Pettijohn, 1980; Wang et al., 1999) . This change is accompanied by speci®c changes in phosphorylation of the NuMA protein (Compton and Luo, 1995; Zeng, 2000) and presumably also by changes in the binding partners with which NuMA interacts, one of these is possibly GAS41. In interphase, NuMA is located in the nucleus as a component of the nuclear matrix (Luderus et al., 1994) . Immunoelectron microscopy shows that nuclear lattices are built from NuMA (Gueth-Hallonet et al., 1998) . These lattices could possibly provide a framework on which nuclear processes, such as transcription, take place. When using the NuMA protein as bait in the yeast two-hybrid system, Harborth et al., 2000 have identi®ed the GAS41 protein as an interacting partner.
We have demonstrated that, like the NuMA protein, GAS41 is also expressed in the nucleus (Figures 5B, 6A and 6B) . GAS41 protein is localized in the nucleoplasm, but not in the nucleoli, of all tested cell lines and cell cultures exclusive of the tested neuroblastoma cell lines. We suggest that the dierent subcellular distributions of the GAS41 protein may be dependent upon the cell type. In addition, the expression of GAS41 in the nucleus is consistent with the location of a transcription domain/factor.
The independent ®ndings of the interaction between GAS41 and NuMA by us and by Harborth et al., 2000 and their common nuclear location make their interaction at some point during the cell cycle highly probable. We suggest a model for the potential multiprotein transcription complex in which GAS41 with its acidic activation domain has the potential to activate transcription in human cells in combination with a second protein containing a DNA-binding domain such as NuMA, for example ( Figure 9 ). It is highly probable that GAS41 builds a speci®c transcription complex with supplementary proteins, as in the yeast SWI-SNF complex (Wang et al., 1996 and Dingwall et al., 1995) , that are essential for the function of the GAS41 protein. Additionally, it is not inconceivable that GAS41 may also interact with prefoldin, which plays an essential role in the folding reaction of native proteins like actin and/or tubulin (Vainberg et al., 1998; Hansen et al., 1999) , as NuMA associates with tubulin microtubules and stabilizes the mitotic spindle during mitosis. Further functional experimentation is required to de®nitively demonstrate the role played by GAS41 within the transcription complex. 
Materials and methods

DNA sequencing
Sequencing was performed according to the manufacturer's instructions using the Perkin Elmer ABIPrism Cycle Sequencing kit. Clone inserts were sequenced with an automated sequencer, LI-COR dna sequencer model 4000L.
Northern blot
A multiple tissue Northern blot obtained from Clontech was hybridized with a [a-32 P]-dATP labeled 220 bp fragment of GAS41 and with a [a-32 P]-dATP labeled 1.3 kb fragment of GAPDH respectively. Hybridization conditions were as described in the manufacturer's instructions (Clontech).
Peptide synthesis
The GAS41-N peptide composed of amino acids 36 ± 48, the GAS41-C peptide composed of amino acids 212 ± 227 ( Figure  1 ) and KIAA 1009 peptide composed of the amino acids CENEENSKNISTMES were synthesized using the Fmoc method of solid phase peptide chemistry (Merri®eld 1963 ) on a Milligen / Biosearch 9050 Pep-Synthesizer. Cleavage of the peptides from the resin and removal of the protecting groups were achieved by treating the peptide with 90% tri¯uoro-acetic acid, 2.5% phenol, 2.5% 1,2-ethanedithiol, 1% triisopropylsilane and 5% water.
Generation of polyclonal antibodies
Antibodies were generated against the peptide plus an additional amino-terminal cysteine. The peptide was coupled to keyhole limpet hemocyanin that had been activated with N-succinimidyl-3-maleinimido-proprionate. To obtain antibodies, rabbits (bastards) were immunized by subcutaneous injections of 300 mg of coupled peptide emulsi®ed in Freund's complete adjuvant (Sigma) (Harlow and Lane 1989) . The immunization was repeated twice at two week intervals with the same amount of coupled peptide in Freund's incomplete adjuvant. The rabbits were bled 8 ± 10 days after immunizations. The sera were tested after each bleeding on recombinant protein by Western blot.
Purification of antibodies
Pre-tested rabbit sera were puri®ed on peptide binding HiTrap TM NHS-activated Sepharose TM HP columns (Amersham Pharmacia BiotechAB, Uppsala, Sweden) according to the manufacturer's instructions.
Cell culture
All cells were cultured in DMEM containing 10% FCS, exclusive to the cell culture of primary astrocytes NHA. These cells were cultured in Astrocyte Growth Medium BulletKit (CellSystems).
Cell fractionation
TX3868 GBM cells were rinsed twice with cold PBS and collected (10 min; 1200 r.p.m.). The cell pellet was washed and then lysed in 2 volumes of lysis buer [10 mM MES (pH 7.9), 10 mM NaCl, 1.5 mM MgCl 2 , 10% Glycerin, 1 mM EDTA, 5 mM DTT, 1% (v/v) NP40 3 mg/ml] 5 min at 48C. The lysate was centrifuged at 1500 r.p.m. for 5 min at 48C and the pellet was lysed in lysis buer. After an additional centrifugation step of 5 min at 6000 r.p.m. at 48C, the supernatant contains the cytoplasmic fraction and the pellet contains the nuclei. The pellet was washed in wash buer (lysis buer without NP40) and centrifuged 5 min at 6000 r.p.m. The pellet was lysed in extraction buer (25 mM Tris-HCl, 1 mM EDTA, 0.5 mM NaCl, 10 mM bMercaptoethanol, 0.6% (v/v) TritonX100) and incubated on ice for 40 min. The cell debris was collected by centrifugation for 30 min at 40 000 r.p.m.
Gel electrophoresis and Western blot
Proteins were subjected to 12.5% SDS ± PAGE for experiments with GAS41 and to 7.5% SDS ± PAGE for experiments with KIAA1009 and transferred to PVDF membranes (Millipore, Bedford). The GAS41-C antibody and the KIAA1009 antibody were used at a 1 : 1000 dilution. Reactive proteins were detected by appropriate Horseradish-peroxidase conjugated anti-IgG antibodies and visualized with the ECL TM Western Blotting Detection Reagent (Amersham Pharmacia Biotech).
Immunofluorescence
We used the following cell lines and cell cultures respectively: a cell culture derived from an astrocytoma grade I (T5498), six cell cultures derived from astrocytomas grade II (T4747, T4761, T4772, T4951, T5184, and T5473), the cell line TX3868 and the GBM cell culture T5135, a meningioma cell culture, the prostate carcinoma cell line PC 3, the breast carcinoma cell line MCF-7, the HeLA cell line, the cell culture of primary astrocytes NHA, the cell line of ®broblasts KH5436, neuroblastoma cell lines SK-N-SH, Neuro 2a, and NS20Y. The cells were grown on coverslips, ®xed with 3.7% formaldehyde for 15 min at room temperature, and permeabilized with 0.1% Triton X-100 in PBS for 15 min at room temperature. The cells were incubated for 1 h with the primary antibody (GAS41-C, 1 : 5 dilution). After washing three times with PBS they were incubated with¯uorescein-conjugated goat anti-rabbit IgG (Jackson Research) for 1 h. The coverslips were then washed three times with PBS and mounted in Vectashield (Vector Laboratories). To demonstrate the same subcellular distribution of GAS41 protein, KIAA1009 protein and NuMA the TX3868 cell line triple labeling was performed by incubation with three proteinspeci®c antibodies and the corresponding secondary antibodies in the following succession: Incubation with GAS41-C (1 : 5),¯uorescein-conjugated goat anti-rabbit IgG (Jackson Research), a KIAA1009-speci®c antibody, Alexa Fluor 594 (Molecular Probes, 2 mg/ml), a NuMA speci®c antibody (Transduction Laboratories; 1 : 25), and AMCA-conjugated AniPure goat anti-mouse IgM, m chain speci®c antibody with minimal cross-reaction to human, bovine, and horse serum proteins (Dianova; 1 : 25). Each antibody incubation took 1 h and the incubation steps were separated by washing three times with PBS.
Immunohistochemical staining
Immunohistochemical staining was performed on formalin ®xed and paran embedded tissue sections using the avidinbiotin peroxidase method. Pre-treatment was performed with microwave and citrate buer for 5 min at 700 W and 5 min at 350 W. The primary antibody, GAS41-C, was applied at a dilution of 1 : 100 for an incubation period of 20 min at 378C. Negative controls were performed by incubating tissue sections with antibody diluent (DAKO) instead of the primary antibody, GAS41-C. The speci®c reaction of GAS41-C antibody was detected with a secondary biotin labeled antibody (swine anti-rabbit /DAKO). Sections were counterstained with hematoxylin after the DAB reaction.
Yeast two-hybrid screening (Stratagene)
For the yeast-two hybrid screen, we used HybriZAP TwoHybrid cDNA Gigapack Cloning Kit (Stratagene). A 630 bp fragment of GAS41 corresponding to bases 300 ± 929 was generated by PCR. The primers were synthesized by an RNA/DNA synthesizer (Applied Biosystems) with the following sequences: GAS41 for (5' -GTC GAC TAC GGT AAT GTT GCT CGG-3') and GAS41 rev (5'-CTG CAG CTA CCA AGT TCT CAT GAG-3'). The puri®ed DNA fragment was PstI/SalI digested at 208C overnight, ligated into the pBD-GAL4-Cam phagemid vector (Stratagene) and transformed in competent E. coli XL1/MRF cells.
The YRG-2 yeast strain was simultaneously transformed with the bait plasmid pBD-GAS41, and the human TX3868 cDNA library cloned into the pAD-GAL4 vector, according to the manufacturer's instructions. Positive interactions were selected by histidine auxotrophy. LacZ activity was determined for all growing colonies using a blue/white ®lter assay according to the manufacturer's instructions. Plasmids from positive clones were extracted and sequenced.
